Innovent Biologics Stock Price Prediction
| IVBXF Stock | USD 4.86 0.03 0.62% |
Oversold Vs Overbought
46
Oversold | Overbought |
Using Innovent Biologics hype-based prediction, you can estimate the value of Innovent Biologics from the perspective of Innovent Biologics response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Innovent Biologics to buy its pink sheet at a price that has no basis in reality. In that case, they are not buying Innovent because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell pink sheets at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Innovent Biologics after-hype prediction price | USD 4.86 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Innovent |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Innovent Biologics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Innovent Biologics After-Hype Price Prediction Density Analysis
As far as predicting the price of Innovent Biologics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Innovent Biologics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of Innovent Biologics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Innovent Biologics Estimiated After-Hype Price Volatility
In the context of predicting Innovent Biologics' pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Innovent Biologics' historical news coverage. Innovent Biologics' after-hype downside and upside margins for the prediction period are 1.25 and 8.47, respectively. We have considered Innovent Biologics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Innovent Biologics is relatively risky at this time. Analysis and calculation of next after-hype price of Innovent Biologics is based on 3 months time horizon.
Innovent Biologics Pink Sheet Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Innovent Biologics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Innovent Biologics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Innovent Biologics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.14 | 3.61 | 0.00 | 0.00 | 0 Events / Month | 1 Events / Month | Uncertain |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
4.86 | 4.86 | 0.00 |
|
Innovent Biologics Hype Timeline
Innovent Biologics is currently traded for 4.86. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Innovent is anticipated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is anticipated to be very small, whereas the daily expected return is currently at -0.14%. %. The volatility of related hype on Innovent Biologics is about 10480.65%, with the expected price after the next announcement by competition of 4.86. About 44.0% of the company shares are owned by institutional investors. The book value of Innovent Biologics was currently reported as 6.54. The company recorded a loss per share of 0.32. Innovent Biologics had not issued any dividends in recent years. Assuming the 90 days horizon the next anticipated press release will be uncertain. Check out Innovent Biologics Basic Forecasting Models to cross-verify your projections.Innovent Biologics Related Hype Analysis
Having access to credible news sources related to Innovent Biologics' direct competition is more important than ever and may enhance your ability to predict Innovent Biologics' future price movements. Getting to know how Innovent Biologics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Innovent Biologics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| SBHMY | Sino Biopharmaceutical Ltd | 0.00 | 0 per month | 0.00 | 0.04 | 0.00 | 0.00 | 25.86 | |
| DTCFF | Defence Therapeutics | 0.00 | 0 per month | 0.00 | (0.01) | 0.00 | 0.00 | 25.87 | |
| ALRN | Aileron Therapeutics | (0.28) | 5 per month | 0.00 | (0.04) | 9.81 | (8.77) | 41.47 | |
| ENLV | Enlivex Therapeutics | (0.03) | 4 per month | 0.00 | (0.08) | 9.03 | (6.15) | 26.52 | |
| LVCLF | Living Cell Technologies | 0.00 | 0 per month | 0.00 | (0.05) | 0.00 | 0.00 | 66.02 | |
| MCET | Multicell Techs | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| HESG | Health Sciences Gr | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| MYMX | Mymetics Corp | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| MRZM | Marizyme | 0.00 | 0 per month | 10.21 | 0.08 | 33.33 | (25.00) | 128.57 |
Innovent Biologics Additional Predictive Modules
Most predictive techniques to examine Innovent price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Innovent using various technical indicators. When you analyze Innovent charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Innovent Biologics Predictive Indicators
The successful prediction of Innovent Biologics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Innovent Biologics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Innovent Biologics based on analysis of Innovent Biologics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Innovent Biologics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Innovent Biologics's related companies.
Story Coverage note for Innovent Biologics
The number of cover stories for Innovent Biologics depends on current market conditions and Innovent Biologics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Innovent Biologics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Innovent Biologics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Innovent Biologics Short Properties
Innovent Biologics' future price predictability will typically decrease when Innovent Biologics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Innovent Biologics often depends not only on the future outlook of the potential Innovent Biologics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Innovent Biologics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 1.5 B |
Complementary Tools for Innovent Pink Sheet analysis
When running Innovent Biologics' price analysis, check to measure Innovent Biologics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Innovent Biologics is operating at the current time. Most of Innovent Biologics' value examination focuses on studying past and present price action to predict the probability of Innovent Biologics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Innovent Biologics' price. Additionally, you may evaluate how the addition of Innovent Biologics to your portfolios can decrease your overall portfolio volatility.
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |